Literature DB >> 32294374

Droplets and Aerosols in the Transmission of SARS-CoV-2.

Matthew Meselson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32294374      PMCID: PMC7179963          DOI: 10.1056/NEJMc2009324

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
To the Editor: Anfinrud et al. now illustrate in the Journal[1] how liquid droplets exhaled during speech can linger in the air. The large particles to which they refer remain airborne only briefly before settling because of gravity; these particles may pose a threat of infection if they are inhaled by persons close by as well as a contact hazard if they are transferred to another person’s nasal or oral passages. In this way, persons infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may contribute to the spread of the infection. Breathing and talking also produce smaller and much more numerous particles, known as aerosol particles, than those visualized in the laser experiment of Anfinrud and colleagues.[2-4] Certain persons called “super spreaders” produce many more aerosol particles than other persons. The diameters of these particles are in the micron range. These particles are too small to settle because of gravity, but they are carried by air currents and dispersed by diffusion and air turbulence. Inhaled droplets and aerosol particles have different sites of deposition in the recipient. Inhaled droplets are deposited in the upper regions of the respiratory tract, from which they may be removed in nasal secretions or carried upward by the mucociliary escalator, to be expelled or swallowed. In contrast, inhaled aerosolized particles can penetrate to the depths of the lungs, where they may be deposited in the alveoli. A recent study, the results of which were also published in the Journal, showed that experimentally produced aerosols containing SARS-CoV-2 virions remained infectious in tissue-culture assays, with only a slight reduction in infectivity during a 3-hour period of observation.[5] Aerosols from infected persons may therefore pose an inhalation threat even at considerable distances and in enclosed spaces, particularly if there is poor ventilation. The possible contribution of infective aerosols to the current pandemic suggests the advisability of wearing a suitable mask whenever it is thought that infected persons may be nearby and of providing adequate ventilation of enclosed spaces where such persons are known to be or may recently have been.
  5 in total

1.  Inhaling to mitigate exhaled bioaerosols.

Authors:  David A Edwards; Jonathan C Man; Peter Brand; Jeffrey P Katstra; K Sommerer; Howard A Stone; Edward Nardell; Gerhard Scheuch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

2.  Aerosol emission and superemission during human speech increase with voice loudness.

Authors:  Sima Asadi; Anthony S Wexler; Christopher D Cappa; Santiago Barreda; Nicole M Bouvier; William D Ristenpart
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

3.  Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering.

Authors:  Philip Anfinrud; Valentyn Stadnytskyi; Christina E Bax; Adriaan Bax
Journal:  N Engl J Med       Date:  2020-04-15       Impact factor: 91.245

Review 4.  Recognition of aerosol transmission of infectious agents: a commentary.

Authors:  Raymond Tellier; Yuguo Li; Benjamin J Cowling; Julian W Tang
Journal:  BMC Infect Dis       Date:  2019-01-31       Impact factor: 3.090

5.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

  5 in total
  109 in total

1.  Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19.

Authors:  Carina Conzelmann; Janis A Müller; Lukas Perkhofer; Konstantin Mj Sparrer; Alexander N Zelikin; Jan Münch; Alexander Kleger
Journal:  Clin Med (Lond)       Date:  2020-08-30       Impact factor: 2.659

2.  Performance evaluation of a lateral flow assay for nasopharyngeal antigen detection for SARS-CoV-2 diagnosis.

Authors:  Marcela Peña-Rodríguez; Oliver Viera-Segura; Mariel García-Chagollán; José Sergio Zepeda-Nuño; José Francisco Muñoz-Valle; Jesús Mora-Mora; Gabriela Espinoza-De León; Gustavo Bustillo-Armendáriz; Fernanda García-Cedillo; Natali Vega-Magaña
Journal:  J Clin Lab Anal       Date:  2021-03-05       Impact factor: 2.352

3.  Photocatalytic Oxidation of PLA/TiO2-Composite Films for Indoor Air Purification.

Authors:  Pattamaphon Chanklom; Torpong Kreetachat; Rotruedee Chotigawin; Kowit Suwannahong
Journal:  ACS Omega       Date:  2021-04-19

4.  First Clinical Appointment after the COVID-19 Lockdown: Reflections from Orthodontic Patients and Their Anxiety Levels.

Authors:  Mehmet Ali Yavan
Journal:  Turk J Orthod       Date:  2021-06

5.  Medical Mask Wearing During Treatment for Patients Undergoing Radiotherapy in COVID-19 Pandemic - An Experience of Protocol Setup and Dosimetric Evaluation for Particle/Proton Beam Therapy.

Authors:  Yu-Ming Wang; Yang-Wei Hsieh; Bing-Shen Huang; Kuo-Chiang Sung; Kuo-Jung Juan; Steve P Lee; Shen-Hao Lee; Eng-Yen Huang
Journal:  Risk Manag Healthc Policy       Date:  2021-03-02

Review 6.  Animal models for SARS-CoV-2 research: A comprehensive literature review.

Authors:  Kabita Pandey; Arpan Acharya; Mahesh Mohan; Caroline L Ng; St Patrick Reid; Siddappa N Byrareddy
Journal:  Transbound Emerg Dis       Date:  2020-12-20       Impact factor: 5.005

7.  COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study.

Authors:  Anke Hildebrandt; Oktay Hökelekli; Lutz Uflacker; Henrik Rudolf; Sören G Gatermann
Journal:  Int J Hyg Environ Health       Date:  2021-05-20       Impact factor: 5.840

8.  Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.

Authors:  Anett Hudák; Annamária Letoha; László Szilák; Tamás Letoha
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

9.  Excretion of SARS-CoV-2 in breast milk: a single-centre observational study.

Authors:  Arun Prasad; Yankappa N; Pradeep Kumar; Bhavesh Kant Chaudhary; Binod Kumar Pati; Monika Anant; Lokesh Kumar Tiwari
Journal:  BMJ Paediatr Open       Date:  2021-06-02

10.  Effects of the COVID-19 pandemic on new patient visits for orthodontic treatment: A comparison of 2020 and the previous 3 years.

Authors:  Mehmet Ali Yavan
Journal:  J World Fed Orthod       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.